PEG-MGF
Also known as: Pegylated mechano growth factor, PEGylated MGF, MGF-Ec (pegylated)
Classification
Peptide
Regulatory Status
not-established
Sources
3
Review
n/a
Overview
PEG-MGF is described as a pegylated synthetic analog of the mechano growth factor (MGF/IGF-1Ec) splice-variant peptide of IGF-1; human mechanism and clinical activity of the pegylated commercial analog are not established.
Evidence and limitations
Human/preclinical evidence breakdown is not available in this record.
Pathways
IGF-1Ec / MGF-related peptide analog (preclinical description)
Interactions & cautions
Drug interactions
other IGF-1, GH, or GHRH-axis agents — Additive endocrine or safety burden is plausible but unstudied for PEG-MGF. (review)
These are observational flags for review, not individualized instructions.
Sources
Educational reference only — not medical advice.
What people report (anecdote)
CLINICAL DATA (from trials)
Adverse events:
None recorded in our sources.
Effects measured:
Human trials: none found.
ANECDOTE
What people report: anecdote, not evidence
Loading…
Submit a claim you saw